CENTOGENE and Denali Therapeutics Extend World's Largest Observational Study on Parkinson's Disease Genetics Seite 1

09.01.2023 - Working together to deliver data-driven, informative genotyping answers to accelerate and de-risk drug discovery, development, and commercialization for Parkinson’s disease (PD)The Rostock International Parkinson's Disease (ROPAD) Study aims to ... Seite 1

Related Keywords

Germany ,Israel ,Argentina ,Belgium ,Brazil ,Italy ,Portugal ,Cambridge ,Cambridgeshire ,United Kingdom ,Spain ,Berlin , ,Rostock International Parkinson Disease ,Biogen Inc ,Rostock International Parkinson ,Denali Therapeutics ,